Oppenheimer Asset Management Inc. lowered its position in Transcat, Inc. (NASDAQ:TRNS) by 50.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 2,842 shares of the scientific and technical instruments company’s stock after selling 2,946 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Transcat were worth $73,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Marshall Wace North America L.P. boosted its holdings in Transcat by 157.5% in the 1st quarter. Marshall Wace North America L.P. now owns 1,545 shares of the scientific and technical instruments company’s stock worth $36,000 after buying an additional 945 shares during the period. Strs Ohio bought a new position in Transcat in the 2nd quarter worth $46,000. Hillsdale Investment Management Inc. bought a new position in Transcat in the 2nd quarter worth $102,000. Charles Schwab Investment Management Inc. bought a new position in Transcat in the 2nd quarter worth $414,000. Finally, California Public Employees Retirement System boosted its holdings in Transcat by 6.0% in the 3rd quarter. California Public Employees Retirement System now owns 19,504 shares of the scientific and technical instruments company’s stock worth $499,000 after buying an additional 1,100 shares during the period. 63.72% of the stock is owned by institutional investors.

TRNS has been the subject of several recent analyst reports. ValuEngine downgraded shares of Transcat from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Roth Capital initiated coverage on shares of Transcat in a report on Thursday, October 31st. They set a “buy” rating and a $34.50 price objective for the company. Zacks Investment Research downgraded shares of Transcat from a “buy” rating to a “hold” rating in a report on Saturday, October 26th. Finally, Dougherty & Co increased their price objective on shares of Transcat from $32.00 to $35.00 and gave the company a “buy” rating in a report on Thursday, October 24th.

TRNS opened at $31.62 on Thursday. The firm has a 50-day simple moving average of $27.81 and a two-hundred day simple moving average of $24.99. Transcat, Inc. has a 52 week low of $17.56 and a 52 week high of $32.36. The company has a market capitalization of $224.89 million, a PE ratio of 33.28, a price-to-earnings-growth ratio of 3.50 and a beta of 0.82. The company has a quick ratio of 1.60, a current ratio of 2.39 and a debt-to-equity ratio of 0.46.

Transcat (NASDAQ:TRNS) last released its quarterly earnings data on Wednesday, October 23rd. The scientific and technical instruments company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.20 by $0.12. Transcat had a net margin of 4.91% and a return on equity of 13.91%. The business had revenue of $41.76 million during the quarter. As a group, sell-side analysts expect that Transcat, Inc. will post 1.09 earnings per share for the current year.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Featured Article: Benefits of owning preferred stock

Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS).

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.